您好,欢迎来到试剂信息网! [登录] [免费注册]
试剂信息网
位置:首页 > 产品库 > ATRA-BA Hybrid
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
ATRA-BA Hybrid
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
ATRA-BA Hybrid图片
CAS NO:1037543-26-2
包装:50 mg
市场价:7260元

产品介绍

产品描述

ATRA-BA hybrid is a mutual prodrug form of all-transretinoic acid and butyric acid .1ATRA-BA hybrid is cleaved to release ATRA and BA in isolated mouse plasma. It inhibits the growth of MDA-MB-231 breast and PC3 prostate cancer cells with GI50values of 0.01 and 1.02 μM, respectively. ATRA-BA (20 μM) has 15-fold greater antiproliferative activity in PC3 cells compared to an equimolar concentration of ATRA and BA.

Cas No.

1037543-26-2

分子式

C31H40O4

分子量

476.65

别名

ATRA-BA Hybrid

储存和溶解度

DMSO:5 mg/mL
Powder: -20°C for 3 years
In solvent: -80°C for 2 years